SBIRs Aren't a Business Model
Every academic spinout seems to start with the same reflex: "We'll get an SBIR." But after advising dozens of academic spinouts, I've seen this safety net become a trap.
Expert insights, strategies, and analysis on university spinouts, medtech commercialization, and the evolving landscape of medical device innovation.
Every academic spinout seems to start with the same reflex: "We'll get an SBIR." But after advising dozens of academic spinouts, I've seen this safety net become a trap.
Every spinout celebrates the TTO license like it's a trophy. But what no one probably told you... your license starts dying the second the ink dries.
In academia, being a luminary gets you everything: grants, labs, citations, people. But in a startup, a luminary might get a meeting, but that alone doesn't build a company.
Our blog covers university spinouts, medtech commercialization strategies, regulatory pathways, IP strategy, business model development, and the transition from academic research to commercial success. We focus on practical insights for researchers, TTOs, and early-stage founders.
We publish new insights regularly, typically 1-2 articles per month. Our content is based on real-world experience working with university spinouts and medtech companies, providing actionable strategies rather than theoretical advice.
Content is written by the Strategic Spinouts team, drawing from our experience accelerating university spinouts from research to acquisition-ready status. We share lessons learned from working with researchers, TTOs, and acquirers across medical devices, diagnostics, and regulated technologies.
Absolutely! We welcome topic suggestions from our readers. If you have specific questions about university spinouts, medtech commercialization, or regulatory pathways that you'd like us to address, please reach out through our contact page.
You can stay updated by visiting our blog regularly, following us on social media, or signing up for our newsletter. We also recommend bookmarking our blog page for easy access to the latest insights on medtech commercialization.
Get the latest insights on university spinouts, regulatory pathways, and medtech commercialization strategies delivered to your inbox.
Get Started